Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-18 Sale | 2024-03-19 4:03 pm | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer | 9,913 | $56.9 | $564,050 | 54,693 (Direct) | View |
| 2024-02-12 Sale | 2024-02-13 4:38 pm | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer | 597 | $67.77 | $40,457 | 64,606 (Direct) | View |
| 2024-01-29 Sale | 2024-01-31 4:18 pm | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer | 367 | $64.14 | $23,539 | 65,203 (Direct) | View |
| 2024-01-22 Sale | 2024-01-23 6:01 pm | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer | 1,384 | $65 | $89,954 | 65,570 (Direct) | View |
| 2024-01-16 Sale | 2024-01-17 4:41 pm | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer | 1,631 | $66.81 | $108,965 | 91,620 (Direct) | View |
| 2023-10-23 Sale | 2023-10-24 4:18 pm | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer | 131 | $46.04 | $6,031 | 51,622 (Direct) | View |
| 2022-08-17 Sale | 2022-08-18 4:02 pm | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 5,000 | $69.5 | $347,500 | 29,250 (Direct) | View |
| 2022-08-11 Sale | 2022-08-12 4:58 pm | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 5,000 | $67 | $335,000 | 34,250 (Direct) | View |
| 2022-08-08 Sale | 2022-08-09 5:16 pm | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 5,000 | $64.5 | $322,500 | 39,250 (Direct) | View |
| 2022-08-04 Sale | 2022-08-08 4:02 pm | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 10,000 | $60.75 | $607,500 | 44,250 (Direct) | View |
| 2022-07-27 Sale | 2022-07-28 4:03 pm | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 5,000 | $57 | $285,000 | 54,250 (Direct) | View |
| 2022-07-19 Sale | 2022-07-21 4:31 pm | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 5,000 | $56.42 | $282,100 | 59,250 (Direct) | View |
| 2022-06-16 Sale | 2022-06-21 4:11 pm | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 10,000 | $41.78 | $417,850 | 49,250 (Direct) | View |
| 2022-04-20 Sale | 2022-04-22 5:35 pm | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 7,000 | $52.53 | $367,710 | 63,481 (Direct) | View |
| 2021-07-21 Sale | 2021-07-22 4:24 pm | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 1,000 | $65 | $65,000 | 51,490 (Direct) | View |
| 2021-07-15 Sale | 2021-07-16 6:40 pm | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 1,000 | $62.3 | $62,300 | 52,490 (Direct) | View |
| 2021-06-15 Sale | 2021-06-16 4:32 pm | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 4,000 | $64.96 | $259,830 | 53,490 (Direct) | View |
| 2021-05-18 Sale | 2021-05-19 4:04 pm | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 2,000 | $55 | $110,000 | 57,490 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-08-12 Exercise | 2024-08-13 4:13 pm | N/A 2029-02-27 | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer | 5,201 | $0 | 75,194 (Direct) | View |
| 2024-08-12 Exercise | 2024-08-13 4:13 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer | 5,201 | $13.85 | 75,194 (Direct) | View |
| 2024-01-16 Option Award | 2024-01-17 4:41 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer | 16,963 | $0 | 91,620 (Direct) | View |
| 2024-01-16 Option Award | 2024-01-17 4:41 pm | N/A 2034-01-15 | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer | 24,666 | $66.3 | 91,620 (Direct) | View |
| 2023-02-21 Option Award | 2023-02-22 06:46 am | N/A 2032-01-20 | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer | 12,769 | $0 | 58,830 (Direct) | View |
| 2023-02-21 Tax Withholding | 2023-02-22 06:46 am | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer | 441 | $58.5 | 58,830 (Direct) | View |
| 2023-02-10 Tax Withholding | 2023-02-14 4:24 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer | 670 | $51.21 | 46,502 (Direct) | View |
| 2023-01-27 Tax Withholding | 2023-01-30 4:45 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer | 367 | $52.77 | 47,172 (Direct) | View |
| 2023-01-20 Tax Withholding | 2023-01-24 5:12 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer | 1,149 | $52.05 | 47,539 (Direct) | View |
| 2023-01-12 Option Award | 2023-01-17 7:28 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer | 19,634 | $0 | 79,533 (Direct) | View |
| 2023-01-12 Option Award | 2023-01-17 7:28 pm | N/A 2033-01-11 | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer | 30,845 | $52.66 | 79,533 (Direct) | View |
| 2022-10-20 Tax Withholding | 2022-10-24 5:10 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 196 | $58 | 29,054 (Direct) | View |
| 2022-08-17 Exercise | 2022-08-18 4:02 pm | N/A 2028-02-04 | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 5,000 | $0 | 29,250 (Direct) | View |
| 2022-08-17 Exercise | 2022-08-18 4:02 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 5,000 | $15.52 | 29,250 (Direct) | View |
| 2022-08-11 Exercise | 2022-08-12 4:58 pm | N/A 2028-02-04 | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 5,000 | $0 | 34,250 (Direct) | View |
| 2022-08-11 Exercise | 2022-08-12 4:58 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 5,000 | $15.52 | 34,250 (Direct) | View |
| 2022-08-08 Exercise | 2022-08-09 5:16 pm | N/A 2028-02-04 | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 5,000 | $0 | 39,250 (Direct) | View |
| 2022-08-08 Exercise | 2022-08-09 5:16 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 5,000 | $15.52 | 39,250 (Direct) | View |
| 2022-08-04 Exercise | 2022-08-08 4:02 pm | N/A 2028-02-04 | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 10,000 | $0 | 44,250 (Direct) | View |
| 2022-08-04 Exercise | 2022-08-08 4:02 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 10,000 | $15.52 | 44,250 (Direct) | View |
| 2022-07-27 Exercise | 2022-07-28 4:03 pm | N/A 2028-02-04 | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 5,000 | $0 | 54,250 (Direct) | View |
| 2022-07-27 Exercise | 2022-07-28 4:03 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 5,000 | $15.52 | 54,250 (Direct) | View |
| 2022-07-19 Exercise | 2022-07-21 4:31 pm | N/A 2028-02-04 | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 5,000 | $0 | 59,250 (Direct) | View |
| 2022-07-19 Exercise | 2022-07-21 4:31 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 5,000 | $15.52 | 59,250 (Direct) | View |
| 2022-06-16 Exercise | 2022-06-21 4:11 pm | N/A 2029-02-27 | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 10,000 | $0 | 49,250 (Direct) | View |
| 2022-06-16 Exercise | 2022-06-21 4:11 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 10,000 | $13.85 | 49,250 (Direct) | View |
| 2022-04-20 Exercise | 2022-04-22 5:35 pm | N/A 2028-02-04 | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 7,000 | $0 | 63,481 (Direct) | View |
| 2022-04-20 Exercise | 2022-04-22 5:35 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 7,000 | $15.52 | 63,481 (Direct) | View |
| 2022-02-10 Option Award | 2022-02-14 4:13 pm | N/A 2032-02-09 | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 11,853 | $0 | 35,433 (Direct) | View |
| 2022-02-10 Tax Withholding | 2022-02-14 4:13 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 271 | $47.12 | 35,433 (Direct) | View |
| 2022-01-21 Option Award(A) | 2022-02-07 8:06 pm | N/A 2032-01-20 | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 33,648 | $0 | 44,020 (Direct) | View |
| 2022-01-28 Tax Withholding | 2022-02-01 6:10 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 434 | $38.59 | 20,530 (Direct) | View |
| 2022-01-21 Option Award | 2022-01-25 4:37 pm | N/A 2032-01-20 | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 25,616 | $0 | 35,988 (Direct) | View |
| 2021-10-20 Option Award | 2021-10-27 4:26 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 882 | $0 | 10,372 (Direct) | View |
| 2021-07-21 Exercise | 2021-07-22 4:24 pm | N/A 2028-02-04 | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 1,000 | $0 | 51,490 (Direct) | View |
| 2021-07-21 Exercise | 2021-07-22 4:24 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 1,000 | $15.52 | 51,490 (Direct) | View |
| 2021-07-15 Exercise | 2021-07-16 6:40 pm | N/A 2028-02-04 | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 1,000 | $0 | 52,490 (Direct) | View |
| 2021-07-15 Exercise | 2021-07-16 6:40 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 1,000 | $15.52 | 52,490 (Direct) | View |
| 2021-06-15 Exercise | 2021-06-16 4:32 pm | N/A 2028-02-04 | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 4,000 | $0 | 53,490 (Direct) | View |
| 2021-06-15 Exercise | 2021-06-16 4:32 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 4,000 | $15.52 | 53,490 (Direct) | View |
| 2021-05-18 Exercise | 2021-05-19 4:04 pm | N/A 2028-02-04 | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 2,000 | $0 | 57,490 (Direct) | View |
| 2021-05-18 Exercise | 2021-05-19 4:04 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 2,000 | $15.52 | 57,490 (Direct) | View |
Ownership | 2021-04-09 4:04 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President | 0 | $0 | 137,448 (Direct) | View |